Registration
THE KPM GROUP DC LLC for ORPHAZYME US, INC.
Firm
Client
Income
—
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 1730/S. 670, STAT Act H.R. 482/S. 350, Newborn Screening Reauthorization Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE LANDES New | — |
| PATROSKI LAWSON New | — |
| BENJAMIN MASON New | Communications Director, Rep. David Young January 2017 - June 2017 |
Pharmacy PHA
H.R. 1730/S. 670, STAT Act H.R. 482/S. 350, Newborn Screening Reauthorization Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE LANDES New | — |
| PATROSKI LAWSON New | — |
| BENJAMIN MASON New | Communications Director, Rep. David Young January 2017 - June 2017 |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| ORPHAZYME A/S | Denmark | Denmark | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.